As for DPP-4 inhibitors and glinides, increased secretion of endogenous insulin through their pharmacological actions is possibly associated with a lack of a beneficial effect of DPP-4 inhibitors or glinides on endothelial function because of the selective insulin resistance in overweight or obese patients with diabetes mellitus. This evidence concerns the gene INS and Insulin resistance.